Oxidative stress, antioxidants, and Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 14, Issue SUPPL. 1, 2000, Pages

  Rottkamp, Catherine A ^a   Nunomura, Akihiko ^b   Raina, Arun K ^a   Sayre, Lawrence M ^a   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Alzheimer disease; Antioxidants; Free radicals; Oxidative stress

Indexed keywords

ANTIOXIDANT; COPPER; IRON;

ALZHEIMER DISEASE; CONFERENCE PAPER; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

ALZHEIMER DISEASE; ANTIOXIDANTS; COPPER; FREE RADICALS; HUMANS; IRON; NEUROFIBRILLARY TANGLES; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 0034050020     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200000001-00010     Document Type: Conference Paper

References (33)

1. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Brit J Psychol 1968;114:797-811.
2. Brown KC, Yang SH, Kodadek T. Highly specific oxidative cross-linking of proteins mediated by a nickel-peptide complex. Biochemistry 1995;34:4733-9.
3. Crowther RA, Olesen OF, Smith MJ, Jakes R, Goedert M. Assembly of Alzheimer-like filaments from full-length tau protein. FEBS Lett 1994;337:135-8.
4. Dean RT, Hunt JV, Grant AJ, Yamamoto Y, Niki E. Free radical damage to proteins: the influence of the relative localization of radical generation, antioxidants, and target proteins. Free Radic Biol Med 1991;11:161-8.
5. Good PF, Perl DP, Bierer LM, Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 1992;31: 286-2.
6. Gou JP, Eyer J, Leterrier JF. Progressive hyperphosphorylation of neurofilament heavy subunits with aging: possible involvement in the mechanism of neurofilament accumulation. Biochem Biophys Res Commun 1995;215:368-76.
7. Hart PJ, Liu H, Pellegrini M, et al. Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis. Protein Sci 1998;7:545-55.
8. Hensley K, Carney JM, Mattson MP, et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A 1994;91:3270-4.
9. Lee MK, Marszalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994;13: 975-88.
10. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998;158:47-52.
11. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1998;2:2557-68.
12. Miller ML, Johnson GVW. Transglutaminase cross-linking of the tau protein. J Neurochem 1995;65:1760-70.
13. Montine TJ, Amarnath V, Martin ME, Strittmatter WJ, Graham DG. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol 1996;148:89-93.
14. Münch G, Schinzel R, Loske C, et al. Alzheimer's disease - synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 1998;105:439-61.
15. Münch G, Taneli Y, Schraven E, et al. The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation. J Neural Transm 1994;8:193-208.
16. Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999;19:1959-64.
17. Odetti P, Angelini G, Dapino D, et al. Early glycoxidation damage in brains from Down's syndrome. Biochem Biophys Res Commun 1998;243:849-51.
18. Oteiza PI. A mechanism for the stimulatory effect of aluminum on iron-induced lipid peroxidation. Arch Biochem Biophys 1994;308: 374-9.
19. Perez M, Valpuesta JM, de Garcini EM, et al. Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am J Pathol 1998;152:1531-9.
20. Premkumar DRD, Smith MA, Richey PL, et al. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 1995;65:1399-402.
21. Sayre LM, Perry G, Harris PLR, Lin Y, Schubert KA, Smith MA. In situ redox catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 2000;74:270-9.
22. Sayre LM, Zelasko DA, Harris PLR, Perry G, Salomon RG, Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997;68: 2092-7.
23. Smith CD, Carney JM, Starke-Reed PE, et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 1991;88:10540-3.
24. Smith MA, Kutty RK, Richey PL, et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 1994b;145:42-7.
25. Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997a;17:2653-7.
26. Smith MA, Harris PLR, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 1997b;94:9866-8.
27. Smith MA, Rudnicka-Nawrot M, Richey PL, et al. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 1995b; 64:2660-6.
28. Smith MA, Sayre LM, Monnier VM, Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci 1995a;18:172-6.
29. Smith MA, Perry G, Richey PL, et al. Oxidative damage in Alzheimer's. Nature 1996a;382:120-1.
30. Smith MA, Siedlak SL, Richey PL, Nagaraj RH, Elhammer A, Perry G. Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease. Brain Res 1996b;717:99-108.
31. Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A 1994a;91;5710-4.
32. Smith MA, Wehr K, Harris PLR, Siedlak SL, Connor JR, Perry G. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res 1998;788:232-6.
33. Takeda A, Perry G, Abraham NG, et al. Overexpression of heme oxygenase in neuronal cells, the possible interaction with tau. J Biol Chem 2000;275:5395-9.